𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tyrosine hydroxylase replacement in experimental Parkinson’s disease with transvascular gene therapy

✍ Scribed by Pardridge, William M.


Book ID
119923113
Publisher
American Society for Experimental NeuroTherapeutics
Year
2005
Tongue
English
Weight
723 KB
Volume
2
Category
Article
ISSN
1545-5343

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Intravenous glial-derived neurotrophic f
✍ Chun-Fang Xia; Ruben J. Boado; Yun Zhang; Chun Chu; William M. Pardridge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

## Abstract ## Background Rats with experimental Parkinson's disease (PD) are treated with intravenous glial‐derived neurotrophic factor (GDNF) plasmid DNA, non‐viral gene therapy using Trojan horse liposomes (THLs) targeted with a monoclonal antibody (MAb) to the rat transferrin receptor (TfR). E

Association study of structural mutation
✍ Kunugi, Hiroshi; Kawada, Yasuhara; Hattori, Mineko; Ueki, Akira; Otsuka, Mieko; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 11 KB 👁 2 views

Tyrosine hydroxylase (TH) gene is the ratelimiting enzyme in the synthesis of catecholamines. Functional polymorphisms of the TH gene may be involved in the pathogenesis of neuropsychiatric diseases such as schizophrenia, affective disorders, and Parkinsonism. This study examined a possible associat

Rarity of debrisoquine hydroxylase gene
✍ Dr. Chi P. Pang; Jun Zhang; Jean Woo; Daniel Chan; Lap K. Law; Shirley F. Tong; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

## Abstract Impaired debrisoquine metabolism resulting from defects in the cytochrome P450 __CYP2D6__‐debrisoquine hydroxylase gene has been shown to be associated with the development of Parkinson's disease(PD). We studied two polymorphisms in this gene in 207 Chinese PD patients and 227 control s